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Abstract
Background: Women in Iran are in great need of effective substance abuse services. The current study was
conducted to investigate the effectiveness of motivational interviewing (MI) for women in treatment for drug use in
Iran.
Method: The sample (N = 60) included women in a drug treatment center in Qazvin (Iran) from August to
December of 2017. The research sample included 60 female drug users randomly assigned to MI or Standard Care
(SC). Prior to randomization women completed a baseline questionnaire and the Relapse Prediction Scale (RPS),
which measures desire (urge) to use and probability of using/not using in risky situations (self-efficacy). MI consisted
of eight 60-min group sessions over a 1-month period, twice weekly. At 2-months follow-up, data were gathered
using a questionnaire similar to baseline. Mixed Model Analysis were used to determine group differences.
Results: Mean age of participants was 30 years and average addiction duration was 7 years. Although the scores of
the desire to use and the probability of drug use were not significant before the intervention, after the intervention,
scores on desire to use and probability of use improved about 81.1% (F: 2230.15, P < 0.001, degrees of freedom: 63,
15) and 81.9%, (F: 749.39, P < 0.001, degrees of freedom: 79, 77), respectively, compared to those of control group.
Conclusion: The results showed that motivational interviewing could decrease desire to use and probability of use
among female drug users. Motivational interviewing could play an important role in improving women’s health in
Iran.
Trial registration: IRCT registration number: IRCT20140907019077N4
Registration date: 2017-12-12, 1396/09/21
Registration timing: registered_while_recruiting
Last update: 2017-12-12, 1396/09/21
Keywords: Motivational interviewing, Female drug user, Relapse, Stages of change model, Addiction
Background
Women and drug abuse
Given Iran’s proximity to a major opioid trade route, illicit
drug use is a major problem in Iran and opioids in particular
are readily available [1–4]. Due to stigma, prevalence re-
search on drug use is scant, although use of stimulants and
injection drugs appears to have increased over time.
Amin-Esmaeli et al., (2016) [4] studied prevalence of
substance use disorders in Iran (N = 7841; N, women =
4475). Prevalence of 12-month use disorder for any drug
was 2.44% with opioid use disorder most common (2.23%)
followed by cannabis (.56%) and amphetamines (.39%).
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Substance disorder was more likely in men, divorced per-
sons and persons of lower socio-economic status; and over
half of the sample had unmet treatment need. Very few
women use substance services and this is likely due to lack
of facilities specializing in women, cost and stigma [4].
Other studies have also found relatively few women seek-
ing substance treatment [2] .
A national survey of emergency hospitals in Iran indi-
cated 2% of women used opium with .05% dependent on
opium and its derivatives [5]. In another national survey in
Iran, about 3.3% of women ages 15 to 64 years had a life-
time history of narcotics and/or stimulants use [5]. There is
a high prevalence of stimulant use, such as crystal metham-
phetamine, in Iran [5]. In a sample of women in substance
treatment, use of crystal meth appears to be associated with
being single and an expectancy that it enhances the ability
to work, whereas use of opium is associated with being
married and having a spouse who is drug-involved [5].
Pre-treatment characteristics of persons in substance
treatment in Iran were examined and only 4% (N = 33)
of the sample was female [1]. Of these women, 63% were
homemakers, 78% had a high school degree or more,
70% were married, 33% were 25–34 years old, and main
drugs of abuse were opium (59%), crystalline heroin
(heroin hydrochloride, 34%) and other drugs (6%). Gha-
deri et al. (2017) studied gender differences in drug use
between Iranian men and women receiving methadone
maintenance treatment (MMT) and found metham-
phetamine use and simultaneous use of multiple sub-
stances during the last 12 months were less common
among women. Similarly, life-time dependence on nico-
tine, heroin and alcohol; and life-time cannabis and
other substance abuse were less common among
women. Among women, the most frequent 12-month
substance diagnosis was opium dependence (42.5%),
whereas the most frequent life-time substance diagnosis
(aside from opioid) was nicotine dependence.
Aside from opioids, 12-month prevalence rates for
common illegally used substances in Iran are as follows:
Alcohol, 2%; cannabis, 1%; and methamphetamine, .5%
[3]. Substance use and dependence are increasing among
women in Iran and therefore, clinics specializing in the
addictions for women are opening [3]. Although women
use substances at lower rates than men, women who are
in need do not get needed and critical intervention.
Therefore, when women do seek treatment, it is import-
ant that they receive intervention that is useful in assist-
ing with change in drug use.
The trans-theoretical model (TTM) and motivational
interviewing (MI)
The TTM is one of the most frequently used and tested
models of behavior change [6]. It provides a foundation
for tailoring interventions based on readiness to change,
the central organizing construct of the TTM [7]. Readi-
ness is characterized in terms of five stages: Pre-
Contemplation (no intention to change in the next 6
mo); Contemplation (intention to change within 6 mo);
Preparation (intends to take action within 30 days and
has a plan); Action (behavior change has occurred); and
Maintenance (change sustained for > 6 mo; see Ha et al.,
2003). Other core constructs include decisional balance,
self-efficacy, and the processes of change [7]. These con-
structs have been validated with many behaviors across
a variety of populations [8]. The TTM has been useful in
designing interventions because it accounts for readiness
to change in tailoring interventions [9].
MI provides an empirically supported style for match-
ing counseling to an individual’s readiness to change
[10].MI represents a practical approach for behavior
change by enhancing a client’s own internally motivated
change process, and dovetails well with other behavioral
interventions including the TTM [11]. Responsibility for
behavior change is assumed to lie within the individual,
and ambivalence is recognized as a natural part of this
change process. MI is designed to assist clients in work-
ing through ambivalence and in moving toward change.
The MI counselor uses techniques including personal-
ized feedback, reflective listening, exploring pros/cons of
change, supporting client self-efficacy, eliciting “self-mo-
tivational statements” (problem recognition, intention to
change, optimism about change), and generating solu-
tions to potential change barriers. Of critical importance,
MI emphasizes the client’s personal choice regarding
change, de-emphasizes labeling the client and his/her
behaviors, and avoids arguing with or confronting the
client with the need to change. Meta-analytic work has
found that MI is efficacious across a variety of settings,
for a wide range of health behaviors including substance
use, risky sex and treatment engagement [12]; appears
particularly useful for minority populations, at least in
the United States [13]; and can be effective in as little as
one session [14, 15].
Study rationale
Women do not access drug treatment when in need,
therefore it is important to provide them with useful
intervention when they do enter treatment. A large lit-
erature base supports use of TTM and MI in making be-
havior change with respect to substance use, and
accounts for cognitive factors during the process of be-
havior change, including dealing with tempting situa-
tions and developing efficacy to avoid substance use.
This study evaluates the use of MI that is informed by
TTM to address women’s reported ability to cope with
tempting situations. It is important because more work
needs to be done to assist women in Iran, use of TTM
and MI should be better evaluated for use outside of
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Western countries, and this study stands to lay the foun-
dation to conduct future research on actual behavior
change.
Methodology
The focus of this trial was to study substance use prob-
lems, including opium use in particular. However, treat-
ment of poly-substance use was identified as a much
greater need during implementation. Therefore, this paper
focuses on treatment of persons with a wide-range of sub-
stance use disorders. Original planned outcomes included
relapse to substance use and results of the Relapse Predic-
tion Scale (RPS; see below). As the planned 2-month
follow-up makes it difficult to observe relapse, this study
focuses on the RPS, which is a more sensitive and realistic
outcome, given the small sample size and brief follow-up.
Sample
It was a parallel trial with a 1 to 1 ratio. The sample
(N = 60) consisted of women ages 15–49 years old re-
ceiving substance intervention at a treatment site in
Qazvin (Iran) in 2017. The inclusion criteria were being
fluent in Farsi (the Iranian official language), not having
any chronic physical health disorder and not being preg-
nant. Healthy volunteers were accepted. A researcher
approached women to ask if they might be interested in
volunteering for a confidential intervention study. Proce-
dures were explained and women could opt out anytime.
Written informed consent was obtained. Women re-
ceived a small gift for completing questionnaires.
Measurements
Basic demographic data were collected on women, includ-
ing age, substance use and so forth. To examine the risk
to return to substance use, the Relapse Prediction Scale
(RPS) was used. The RPS consistes of 45 items (Wright,
Beck, Newman & Liese, 1993) [16]. Each item consists of
a situation where the respondent rates strength of urge to
use and likelihood of use.
For example, it is expressed as the following questions,
where each item is rated for urge and probability, separately:
1. I am in a place where I have used drugs before.
2. I am with the people whom I have used drugs with.
3. I see my husband who uses drugs.
All the questions are graded on a 5-point Likert type
scale consisting of 0-none, 1-poor, 2-moderate, 3-
strong, 4- very strong. Scores rage from 0 to 180 for urge
and likelihood of use, separately, with higher scores
representing more risk. Prior studies of the Farsi/Per-
sian-translated version indicate internal consistencies
ranging from .74 to .81 [17, 18]. Gholami & Shareh
(2015) [3] found that the scales distinguished between
treatment and control groups as expected in substance-
dependent persons (e.g., craving and likelihood of drug
use was reduced), supporting scale validity. In the
current research, Cronbach’s alpha was found to be 0.91.
Implementation method
At baseline, women completed an assessment, including
the RPS via interview with a researcher blind to study con-
dition. The sample then was randomly assigned to experi-
mental intervention and standard care (SC). Randomization
was achieved using sealed, opaque, sequentially numbered
envelopes developed from a random number generator. A
research assistant who was not involved in the recruitment
of participants prepared the envelopes. Experimental
Table 1 The structure and contents of motivational interviewing sessions
Session Content
First Introduction: Norms and procedures of group, introducing motivational
interviewing and stages of change, determining stage of change.
Second Describing a typical day: Describing substance use in terms of quantity,
physiological effects, signs of substance problems. How to monitor
substance use with a screening log.
Third Expectations: Discussing what we think substances do for us, why we
take them, the good and not so good of use.
Fourth Self-efficacy and temptation: Recognizing triggers and tempting situations;
comparing tempting situations and confidence to use or not in these
situations.
Fifth Rewarding successes: How to recognize successes, setting goals and then
rewarding yourself.
Sixth Efficacy: Practicing refusal of drugs using role plays.
Seventh Urge: Dealing with urges, how to avoid them and cope with them,
identifying other enjoyable activities, alternatives to substance use.
Eighth Slips: Using a slip to learn, reviewing past reasons for changing use, resources
available and what can be done after a slip; summary and conclusion.
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intervention consisted of group-based MI sessions held for
eight 60-min sessions (see Table 1). Sessions occurred over
a 1-month period, twice weekly. SC included 4 sessions of
individual counseling in which women were encouraged to
seek outside support, including self-help, which is the most
commonly used substance intervention in Iran [4] . These
sessions occurred at once per week. At 2-months follow-
up, data were gathered using a questionnaire similar to
baseline questionnaire. Women were in the program 10–
14 days before interventions began. At follow-up they were
no longer in the treatment facility. Baseline and follow-up
assessments were conducted by research staff and not inter-
vention providers for both treatment groups.
MI sessions
MI sessions were based on, “Group treatment for substance
abuse: A stages-of-change therapy manual”, which has been
translated to Farsi [19]. Table 1 presents structure and con-
tent of sessions. Consistent with MI, sessions incorporated
affirmations, open questions, reflections and selective sum-
mary to ellicit desire, ability, reason, need and commitment
to change [20]. Interventionists met women where they
were in their desire to change (e.g., precontemplation, mak-
ing changes, etc); utilized decisional balance (pros/cons of
change) to enhance interest in change; assisted women to
enhance self-efficacy for change (“what about you makes
you think you could make a change if you decided?”); and
Fig. 1 Flow diagram of the study participants
Table 2 Drug Use Rates by Treatment Group
Experimental group Control group
Daily Weekly Monthly Irregularly Daily Weekly Monthly Irregularly
N % N % N % N % N % N % N % N %
Other drugs 19 63 3 10 2 6.6 6 20 20 66.6 2 6.6 0 0 8 26.6
Heroin 23 76 2 6.6 2 6.6 5 16.6 18 60 2 6.6 0 0 10 33.3
Opium 15 50 10 33.3 4 13.3 1 3.3 16 53.3 4 13.3 2 6.6 6 20
Meth-amphet-amines 28 93 0 0 0 0 2 6.6 29 96.6 0 0 0 0 1 3.3
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examined tempting situations to assist them in problem-
solving risky situations. These techniques are reflected in
the TTM and are consistent with MI.
Providers led the sessions for attendees, and those
who offer MI sessions did not offer standard care drug
treatment sessions. Providers had 30 h of training using
materials in Miller & Rollnick (2013) and Prochaska
et al. [9, 21]. Training was conducted by EB. Supervision
occurred every other week for the duration of the study
and included role-plays with feedback and case
discussion.
Standard care (SC) treatment
SC generally did not involve medication assisted treatment for
substance use. SC included weekly doctor visits and twice a
week sessions guided by a non-profit organization, “Addicts
Anonymous”. In addition, 4 sessions were delivered by a
psychologist covering general psycho-education on drugs, and
basic behavioral techniques including drug-refusal skills [22].
Statistical analysis
Statistical Package for the Social Sciences-version 22
(SPSS Inc., Chicago, IL, USA) was used to conduct de-
scriptive and inferential statistics. Differences in sociode-
mographic characteristics between groups were assessed
using a t-test and chi-squared. At first all data were
checked for normality using Kolmogrov-Sminov test;
data met normality assumptions. Mean differences be-
tween intervention groups were compared in repeated
measures analysis. In particular, mixed model repeated
measures analyses were used to determine the effect of
intervention on urge (desire to use) and probability of
use (or efficacy). A p-value of < 0.05 was considered sta-
tistically significant.
Considering the mean and standard deviation of re-
lapse from a previous study [23], using the below for-
mulla with α = 0.05 and β = 0.1, a sample of 30 was







The study was approved by the Ethics Committee of
Qazvin University of Medical Sciences (IR.QUMS.-
REC.1396120). All participant asked to give informed
consent.





Variables Mean (SD) Mean (SD) P Value
Age 30.93 (7.47) 30.90 (7.76) 0.9a
Years of addiction 6.90 (7.83) 6.49 (7.37) 0.7a
N (%) N (%)
Income poor 15 (50) 14 (46.6) 0.1b
Above moderate 15 (50) 16 (53.4)
Education Lower than high school diploma 21 (70) 21 (70) 0.5b
Higher than High school diploma 9 (30) 9 (30)
Rehabilitation experience Yes 23 (76.7) 18 (60) 0.1b
No 7 (23.3) 12 (40)
Addiction among family members Yes 26 (86.7) 25 (83.3) 0.7b
No 4 (13.3) 5 (16.7)
• aUsing t test
•bsing chi-square test
Table 4 Comparisons of the urge and likelihood of substance abuse between two groups using Mixed Model Analysis
Before intervention After intervention F DF P
Intervention (n = 30) Control (n = 30) Intervention (n = 30) Control (n = 30)
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Probability of substance abuse 3.33 (0.67) 3.27 (0.34) 0.60 (0.41) 2.91 (0.32) 2230.15 63, 15 0.001
Desire for substance abuse 3.17 (0.60) 3.52 (1.06) 0.58 (0.23) 3.05 (0.41) 749.39 79, 77 0.001
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Results
The average age of participants was 30 years old and
both groups were not significantly different in terms of
education and income P > 0.05. Figure 1 shows flow dia-
gram of the study. The highest rate of substance use was
associated with methamphetamine and heroin in both
groups (see Table 2 for description of other drugs). An
average duration of addiction was reported as 7 years.
Also, women reported seeking treatment 2–3 times pre-
viously. Both groups had relatives who were drug users,
particularly their husbands. In brief, both groups were
not significantly different in terms of demographics
characteristics, P > 0.05. (See Table 3.)
The descriptive statistics of the RPS are provided in
the Table 4. As observed in the table, the results reflect
the effectiveness of MI (P > 0.001).
Discussion
As compared to women randomized to standard care
(SC), women randomized to motivational interviewing
(MI) significantly reduced both desire (urge) to use sub-
stances and reported probability of using in tempting situ-
ations (i.e., self-efficacy improved). Results are consistent
with prior research in the filed [24].
Addiction is often a relapsing condition (most of the
women had been in treatment multiple times) and is as-
sociated with much stigma and ambivalence around
change. Therefore, MI may be particularly useful in re-
ducing substance abuse in that it meets women where
they are in change (or cycling through stages of change),
assists women to resolve ambivalence, and is non-
judgmental and person-centered [20].
Limitation
Results may not generalize to addicted women in other set-
tings since the samples were recruited from one rehabilita-
tion center. Women were in a treatment program when
they responded, which might have biased their responses.
Also, there was no behavioral outcome included such as ac-
tual drug use following release from the facility. In addition,
differences in treatment exposure (MI and SC had 8 and 4
sessions, respectively) could account for group differences.
Also we did not assess family support, which may impact
relapse.
Conclusion
Results showed that motivational interviewing can de-
crease desire (urge) to use and reported probability of
use (i.e., improve self-efficacy) among female drug users.
Motivational interviewing could play an important role
in improving women’s health in Iran, although it is not
regularly used currently in Iran. This study is a critical
first step at adapting and evaluating MI in Iranian
women to reduce substance use. It is important to evalu-
ate MI and TTM-informed interventions in non-
Western countries. Findings are encouraging and future
work should evaluate behavioral outcomes in larger
samples.
Abbreviation
RPS: Relapse Prediction Scale
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